Literature DB >> 33853962

Bone Marrow-Derived SH-SY5Y Neuroblastoma Cells Infected with Kaposi's Sarcoma-Associated Herpesvirus Display Unique Infection Phenotypes and Growth Properties.

Xiaohong Kong1, Dongmei Li1, Amirsalar Mansouri2, Guobin Kang1, Khalid Sayood2, John West1,3, Charles Wood1,3,4.   

Abstract

Kaposi's sarcoma-associated herpesvirus (KSHV) is an important oncogenic virus previously shown to be neurotropic, but studies on neuronal cell infection and pathogenesis are still very limited. Here, we characterized the effects of KSHV infection on neuronal SH-SY5Y cells by the recombinant virus rKSHV.219, which expresses both green fluorescent protein (GFP) and red fluorescent protein (RFP) to reflect the latent and lytic phases of infection. We demonstrated that infected cells have a higher growth rate and that KSHV infection can be sustained. Interestingly, the infected cells can transition spontaneously back and forth between lytic and latent phases of infection, producing progeny viruses but without any adverse effects on cell growth. In addition, transcriptome analysis of viral and cellular genes in latent and lytic cells showed that unlike other infected cell lines, the latently infected cells expressed both latent and most, but not all, of the lytic genes required for infectious virion production. The viral genes uniquely expressed by the lytic cells were mainly involved in the early steps of virus binding. Some of the cellular genes that were deregulated in both latently and lytically infected cells are involved in cell adhesion, cell signal pathways, and tumorigenesis. The downregulated cellular CCDN1, PAX5, and NFASC and upregulated CTGF, BMP4, YAP1, LEF1, and HLA-DRB1 genes were found to be associated with cell adhesion molecules (CAMs), hippo signaling, and cancer. These deregulated genes may be involved in creating an environment that is unique in neuronal cells to sustain cell growth upon KSHV infection and not observed in other infected cell types. IMPORTANCE Our study has provided evidence that neuronal SH-SY5Y cells displayed unique cellular responses upon KSHV infection. Unlike other infected cells, this neuronal cell line displayed a higher growth rate upon infection and can spontaneously transition back and forth between latent and lytic phases of infection. Unlike other latently infected cells, a number of lytic genes were also expressed in the latent phase of infection in addition to the established latent viral genes. They may play a role in deregulating a number of host genes that are involved in cell signaling and tumorigenesis in order to sustain the infection and growth advantages for the cells. Our study has provided novel insights into KSHV infection of neuronal cells and a potential new model for further studies to explore the underlying mechanism in viral and host interactions for neuronal cells and the association of KSHV with neuronal diseases.

Entities:  

Keywords:  Kaposi’s sarcoma-associated herpesvirus; cellular response; latent infection; lytic infection; neuronal cell infection

Mesh:

Year:  2021        PMID: 33853962      PMCID: PMC8315978          DOI: 10.1128/JVI.00003-21

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  63 in total

1.  Cellular tropism and viral interleukin-6 expression distinguish human herpesvirus 8 involvement in Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease.

Authors:  K A Staskus; R Sun; G Miller; P Racz; A Jaslowski; C Metroka; H Brett-Smith; A T Haase
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

2.  The KEGG databases at GenomeNet.

Authors:  Minoru Kanehisa; Susumu Goto; Shuichi Kawashima; Akihiro Nakaya
Journal:  Nucleic Acids Res       Date:  2002-01-01       Impact factor: 16.971

3.  An interleukin-6-related systemic inflammatory syndrome in patients co-infected with Kaposi sarcoma-associated herpesvirus and HIV but without Multicentric Castleman disease.

Authors:  Thomas S Uldrick; Victoria Wang; Deirdre O'Mahony; Karen Aleman; Kathleen M Wyvill; Vickie Marshall; Seth M Steinberg; Stefania Pittaluga; Irina Maric; Denise Whitby; Giovanna Tosato; Richard F Little; Robert Yarchoan
Journal:  Clin Infect Dis       Date:  2010-08-01       Impact factor: 9.079

4.  A cluster of latently expressed genes in Kaposi's sarcoma-associated herpesvirus.

Authors:  D Dittmer; M Lagunoff; R Renne; K Staskus; A Haase; D Ganem
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

Review 5.  KSHV and Kaposi's sarcoma: the end of the beginning?

Authors:  D Ganem
Journal:  Cell       Date:  1997-10-17       Impact factor: 41.582

6.  The ubiquitin E3 ligase RAUL negatively regulates type i interferon through ubiquitination of the transcription factors IRF7 and IRF3.

Authors:  Yanxing Yu; Gary S Hayward
Journal:  Immunity       Date:  2010-12-14       Impact factor: 31.745

7.  Glutamate secretion and metabotropic glutamate receptor 1 expression during Kaposi's sarcoma-associated herpesvirus infection promotes cell proliferation.

Authors:  Mohanan Valiya Veettil; Dipanjan Dutta; Virginie Bottero; Chirosree Bandyopadhyay; Olsi Gjyshi; Neelam Sharma-Walia; Sujoy Dutta; Bala Chandran
Journal:  PLoS Pathog       Date:  2014-10-09       Impact factor: 6.823

Review 8.  KSHV LANA--the master regulator of KSHV latency.

Authors:  Timsy Uppal; Sagarika Banerjee; Zhiguo Sun; Subhash C Verma; Erle S Robertson
Journal:  Viruses       Date:  2014-12-11       Impact factor: 5.048

9.  Variable episomal silencing of a recombinant herpesvirus renders its encoded GFP an unreliable marker of infection in primary cells.

Authors:  Thomas J Ellison; Dean H Kedes
Journal:  PLoS One       Date:  2014-11-17       Impact factor: 3.240

10.  Infection and transmission dynamics of rKSHV.219 in primary endothelial cells.

Authors:  Hannah C Jeffery; Rachel L Wheat; David J Blackbourn; Gerard B Nash; Lynn M Butler
Journal:  J Virol Methods       Date:  2013-06-10       Impact factor: 2.014

View more
  1 in total

1.  miR-34a-5p inhibits the malignant progression of KSHV-infected SH-SY5Y cells by targeting c-fos.

Authors:  Shuyuan Wu; Zhaofu Wu; Huiling Xu; Jinli Zhang; Wenyi Gu; Xiaohua Tan; Zemin Pan; Dongdong Cao; Dongmei Li; Lei Yang; Dongmei Li; Yuanming Pan
Journal:  PeerJ       Date:  2022-04-15       Impact factor: 3.061

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.